Health Insurance Policies for Allergy, Asthma & Related Conditions

Inhalers (controller and rescue), nebulizer solutions, spacers, spirometry/pulmonary function testing, specialist (pulmonology/allergy) visits, and biologic therapies for severe asthma (e.g., omalizumab, mepolizumab, benralizumab, tezepelumab) are generally covered under prescription drug and outpatient benefits of ACA-compliant plans. Step therapy and prior authorization are common for biologics.

Epinephrine auto-injectors, skin prick testing, specific IgE blood tests, oral food challenges, allergist visits, and oral immunotherapy (e.g., Palforzia for peanut, FDA-approved 2020) may be covered; coverage for OIT and specialty formulas (e.g., amino-acid formulas for FPIES/EoE) varies by plan and often requires prior authorization.

Emergency department visits, ambulance transport, and epinephrine are covered under emergency services (an ACA Essential Health Benefit). The ACA requires plans to cover emergency services without prior authorization and at in-network cost-sharing levels regardless of whether the facility is in-network, though balance billing protections vary.

Endoscopies with biopsy, specialist visits, elimination diets supervised by dietitians, and medications (e.g., proton pump inhibitors, swallowed topical steroids; Dupixent is FDA-approved for EoE in adults and pediatric patients 12+ as of 2024). Coverage of off-label therapies and biologic step therapy is common.

Diagnostic serology and endoscopy with biopsy are covered; gluten-free food itself is generally NOT covered (it is a grocery expense, not a medical service), though some plans/HSA/FSA arrangements may allow reimbursement with a Letter of Medical Necessity. Dietary counseling with a registered dietitian may be covered as a preventive or therapy benefit.

Diagnosis (specific IgE testing for galactose-alpha-1,3-galactose), anaphylaxis treatment, epinephrine auto-injectors, and allergist visits are generally covered. Because mammalian-derived ingredients can appear in some medications, patients may need formulary coordination with their prescriber and pharmacist.

Specialist (allergy/immunology or hematology) visits, tryptase testing, bone marrow biopsy (for systemic mastocytosis), and trigger management medications (H1/H2 antihistamines, mast cell stabilizers, leukotriene modifiers; tyrosine kinase inhibitors for advanced systemic mastocytosis) may be covered. Off-label use of antihistamines/mast cell stabilizers is common and may require appeals.

Intranasal steroids, antihistamines, leukotriene modifiers, immunotherapy (subcutaneous and sublingual — sublingual coverage varies), and biologics for chronic rhinosinusitis with nasal polyps (e.g., Dupixent, Xolair, mepolizumab) may be covered; biologics typically require step therapy and prior authorization.

Topical therapies, emollients (often OTC), phototherapy, and biologics (e.g., Dupixent, Adbry, Rinvoq, Cibinqo) are generally covered; OTC moisturizers are typically not covered unless prescribed and plan allows.

Antihistamines (often up-dosed off-label), leukotriene modifiers, and biologic therapy (omalizumab is FDA-approved for CSU) may be covered; high-dose antihistamine step therapy and prior authorization for biologics are common.

Smoking cessation (tobacco cessation is an ACA required preventive service with no cost-sharing for qualifying plans), bronchodilators, inhaled corticosteroids, pulmonary rehabilitation (covered by Medicare Part B when criteria met), oxygen therapy, and lung function testing are generally covered benefits.

Allergy testing, venom immunotherapy (for insect sting allergy), challenge/desensitization procedures, and epinephrine are generally covered. Latex-free product substitution is usually a facility rather than an insurance benefit.